| Typicality: | 0.486 |
| Saliency: | 0.375 |
| beyond prostaglandins | 5 | other |
| in tumors | 3 | location |
| specifically | 2 | manner |
| drug → target → pathway | 36 |
| drug → target → molecular pathways | 6 |
| drug → target → signaling pathways | 5 |
| drug → target → molecular pathway | 3 |
| negative | neutral | positive |
| 0.104 | 0.653 | 0.243 |
| Raw frequency | 50 |
| Normalized frequency | 0.375 |
| Modifier score | 0.733 |
| Perplexity | 85.404 |